Inflammatory bowel diseases (IBD) are a group of chronic, debilitating disorders of the gastrointestinal tract with peak onset in adolescence and early adulthood. More than 1.4 million people are affected in the USA, with an estimated direct healthcare cost of $6.3 billion per year. The pathogenesis of IBD is not clear but previous studies have found IBD highly heritable. Therefore, studying the genetic basis of IBD is a natural path towards elucidating the IBD pathogenesis and will ignite the much-needed progress toward novel IBD therapeutics. Genome-wide association studies (GWAS) have identified over 200 loci associated with IBD. However, most IBD-causing low frequency and rare variants have yet to be discovered as GWAS only captures common variants. Sequencing studies can capture rare and low frequency variants but there has not been a well powered study yet. This study proposes an exome-wide association analysis on the recently generated IBD data from CCDG, a new and better powered dataset, with the goal to identify novel IBD genetic associations driven by low frequency coding variants. Results from this study will be promptly released and contributed to other IBD genetics studies. The new IBD causal variants, biological pathways and genetic mechanisms from this study will provide new insights into IBD pathogenesis, make important positive impact and serve as the fundamental resource and basis toward novel IBD therapeutics.

Public Health Relevance

Inflammatory bowel diseases (IBD) are a group of inheritable, chronic disorders of the gastrointestinal tract affecting more than 1.4 million people in the U.S. with a direct healthcare cost of $6.3 billion/year. This proposal will be using exome-sequencing analyses to identify genes underlying IBD for insights into the disease pathogenesis.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Scientist Development Award - Research & Training (K01)
Project #
3K01DK114379-04S1
Application #
10236691
Study Section
Program Officer
Saslowsky, David E
Project Start
2017-09-15
Project End
2021-07-31
Budget Start
2020-08-01
Budget End
2021-07-31
Support Year
4
Fiscal Year
2021
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
02114
Li, Dalin; Haritunians, Talin; Landers, Carol et al. (2018) Late-Onset Crohn's Disease Is A Subgroup Distinct in Genetic and Behavioral Risk Factors With UC-Like Characteristics. Inflamm Bowel Dis 24:2413-2422
Rivas, Manuel A; Avila, Brandon E; Koskela, Jukka et al. (2018) Insights into the genetic epidemiology of Crohn's and rare diseases in the Ashkenazi Jewish population. PLoS Genet 14:e1007329
Moran, Christopher J; Huang, Hailiang; Rivas, Manuel et al. (2018) Genetic variants in cellular transport do not affect mesalamine response in ulcerative colitis. PLoS One 13:e0192806
Simeonov, Dimitre R; Gowen, Benjamin G; Boontanrart, Mandy et al. (2017) Discovery of stimulation-responsive immune enhancers with CRISPR activation. Nature 549:111-115
Huang, Hailiang; Duggal, Priya; Thio, Chloe L et al. (2017) Fine-mapping of genetic loci driving spontaneous clearance of hepatitis C virus infection. Sci Rep 7:15843